CC-486 (oral azacitidine) maintenance therapy is well tolerated after allogeneic hematopoietic stem cell transplantation (AlloHSCT) in patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) Meeting Abstract
| Authors: | de Lima, M.; Oran, B.; Papadopoulos, E. B.; Scott, B. L.; William, B. M.; Giralt, S. A.; Champlin, R. E.; Hetzer, J.; Tosolini, A.; Laille, E.; Skikne, B. S.; Craddock, C. |
| Abstract Title: | CC-486 (oral azacitidine) maintenance therapy is well tolerated after allogeneic hematopoietic stem cell transplantation (AlloHSCT) in patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) |
| Meeting Title: | 2016 BMT Tandem Meetings |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 22 |
| Issue: | 3 Suppl. 1 |
| Meeting Dates: | 2016 Feb 18-22 |
| Meeting Location: | Honolulu, HI |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2016-03-01 |
| Start Page: | S312 |
| End Page: | S313 |
| Language: | English |
| ACCESSION: | WOS:000370910300463 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2015.11.784 |
| Notes: | Meeting Abstract: 462 -- Source: Wos |
